Related Experiment Video
Updated: May 4, 2026

08:35
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
3.6K
[Evolution of treatment options for hypertension]
Voenno-Meditsinskii Zhurnal
|December 18, 2013
Summary
Hypertension research evolved through four stages, from monitoring to complex treatments targeting risk factors. Despite advances, its clinical impact on the brain and heart persists, driving structural changes.
Area of Science:
- Cardiovascular Medicine
- Medical History
Context:
- Hypertension emerged as a significant medical concern in the early 20th century due to its widespread prevalence.
- The understanding and management of hypertension have evolved in tandem with scientific and technological advancements throughout history.
Purpose:
- To delineate the historical progression of clinical research into the etiopathogenesis of hypertension.
- To trace the evolution of therapeutic strategies from early monitoring to sophisticated, risk-factor-based interventions.
Summary:
- The research outlines four distinct stages in hypertension study: initial monitoring (late 19th-early 20th century), early therapeutic attempts based on neurohumoral concepts (early-mid 20th century), the introduction of key drug classes (late 1950s-early 1970s), and the discovery of the renin-angiotensin-aldosterone system leading to risk stratification (late 20th-early 21st century).
- Despite these advancements, the clinical presentation of hypertension, particularly its impact on cerebral and cardiac systems, has remained largely unchanged over the past century.
- Hypertension continues to be a primary driver of structural alterations in cardiac muscle and vessel walls.
Impact:
- Highlights the enduring clinical manifestations of hypertension, emphasizing its persistent role in cardiovascular disease progression.
- Underscores the importance of understanding the historical trajectory of medical research in addressing chronic conditions like hypertension.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
1.0K
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
1.0K
Hypertension II: Pathophysiology
1.8K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
Hypertension III: Clinical Manifestations and Diagnostic Studies
886
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
886
Heart Failure V: Medical Management
626
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
626
Hypertension I: Introduction
1.2K
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
615
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
615

